BTC Capital Management Inc. Acquires New Holdings in Stryker Co. (NYSE:SYK)

BTC Capital Management Inc. acquired a new stake in Stryker Co. (NYSE:SYKFree Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,399 shares of the medical technology company’s stock, valued at approximately $859,000.

Other large investors have also recently added to or reduced their stakes in the company. Carnegie Capital Asset Management LLC grew its position in shares of Stryker by 0.5% during the fourth quarter. Carnegie Capital Asset Management LLC now owns 96,241 shares of the medical technology company’s stock worth $28,820,000 after buying an additional 497 shares in the last quarter. Atlantic Edge Private Wealth Management LLC acquired a new stake in shares of Stryker during the fourth quarter worth approximately $1,561,000. CoreCap Advisors LLC grew its position in shares of Stryker by 3.9% during the fourth quarter. CoreCap Advisors LLC now owns 5,030 shares of the medical technology company’s stock worth $1,506,000 after buying an additional 191 shares in the last quarter. Consolidated Planning Corp acquired a new position in Stryker in the fourth quarter worth $205,000. Finally, Meritage Portfolio Management acquired a new position in Stryker in the fourth quarter worth $569,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Citigroup raised their target price on Stryker from $362.00 to $406.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Needham & Company LLC upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price target on the stock in a research report on Wednesday, May 22nd. Wells Fargo & Company lifted their price target on Stryker from $364.00 to $381.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 1st. Evercore ISI lifted their price target on Stryker from $340.00 to $370.00 and gave the stock an “outperform” rating in a research note on Thursday, April 4th. Finally, UBS Group lifted their price target on Stryker from $339.00 to $351.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $370.58.

View Our Latest Report on Stryker

Stryker Stock Up 0.4 %

SYK opened at $342.64 on Friday. The business has a 50 day moving average price of $336.68 and a 200 day moving average price of $331.65. Stryker Co. has a twelve month low of $249.98 and a twelve month high of $361.41. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.99 and a current ratio of 1.71. The firm has a market cap of $130.53 billion, a P/E ratio of 39.11, a price-to-earnings-growth ratio of 2.69 and a beta of 0.92.

Stryker (NYSE:SYKGet Free Report) last released its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. The business had revenue of $5.24 billion for the quarter, compared to analysts’ expectations of $5.10 billion. Stryker had a return on equity of 23.05% and a net margin of 16.03%. Stryker’s quarterly revenue was up 9.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.14 earnings per share. Research analysts forecast that Stryker Co. will post 11.95 EPS for the current year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Shareholders of record on Friday, June 28th will be given a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 0.93%. The ex-dividend date is Friday, June 28th. Stryker’s dividend payout ratio (DPR) is 36.53%.

Stryker Profile

(Free Report)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Featured Articles

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.